IRB Study Number 17-791
Status Recruiting
Location Cleveland Clinic Main Campus
Institute Digestive Disease & Surgery Institute
Description
The Cleveland Clinic Breast Center aims to develop a targeted microbiome biorepository, with the goal of collecting specimens in the sterile method required to preserve the integrity of the microbiome within breast cancer patients. Differences will be studied in the microbiome specimens, comparing between those with breast cancer, those at higher risk for breast cancer, and those without breast cancer. This will be assessed by collecting blood, stool, urine, and tissue, when applicable.
Inclusion Criteria
- Adult female patients (≥18 years of age) ;
- Patient at the Cleveland Clinic Main Campus Breast Center;
- Subjects must be willing to sign informed consent document;
Exclusion Criteria
- Bladder Surgery or GI Surgery within the past year, Ulcerative Colitis, Crohn’s Disease, Active Diverticulitis, Active Difficile Infection (“C. Diff”), or Fecal Microbiota Transplant
